Erica Jordan, Chief Commercial Officer at Revance Therapeutics, Inc. (RVNC), sold 2,392 shares at $3.80 ($9K) on 2024-04-16, disclosed to the SEC on 2024-04-17.
Open-market sale of $9k RVNC by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.